Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).
- Resource Type
- Journal
- Authors
- Catenacci, Daniel V. T.; Park, Haeseong; Uronis, Hope Elizabeth; Kang, Yoon-Koo; Lacy, Jill; Enzinger, Peter C.; Park, Se Hoon; Lee, Keun Wook; Ng, Matthew C. H.; Gold, Philip Jordan; Yen, Jennifer; Franovic, Aleksandra; Kelly, Ronan Joseph; Wynter-Horton, Aisha; Li, Daner; Muth, John; Baughman, Jan E.; Hong, Sam; Davidson-Moncada, Jan Kenneth; Bang, Yung-Jue
- Source
- JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2018, 36 15, 1p. Supplement: S
- Subject
- Language
- English
- ISSN
- 15277755